Resources

Developing the guidance involved active participation from all stakeholder groups including patients, medical experts, academics and biopharmaceutical industry representatives. This guidance has been submitted to FDA.

Learn how this valuable tool developed by ARC is giving healthcare professionals easy access to critical and current medical information and improving diagnosis.